1h Free Analyst Time
The global neurodegenerative diseases therapeutics market is forecasted to grow by USD 26.49 billion during 2025-2030, accelerating at a CAGR of 9.0% during the forecast period. The report on the global neurodegenerative diseases therapeutics market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.Speak directly to the analyst to clarify any post sales queries you may have.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by rapidly aging global demographic and rising disease prevalence, breakthroughs in biomarker discovery and early diagnostic technologies, increased funding and favorable regulatory pathways.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.
The global neurodegenerative diseases therapeutics market is segmented as below:
By Indication
- Multiple sclerosis
- Alzheimers disease
- Parkinsons disease
- Huntingtons disease
- Others
By Drug Class
- Immunomodulators
- Interferons
- Decarboxylase inhibitors
- Dopamine agonists
- Others
By Route Of Administration
- Oral
- Injection
- Transdermal
By End-User
- Hospital pharmacy
- Retail pharmacy
- Online pharmacy
By Geography
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- UK
- France
- Italy
- Spain
- The Netherlands
- Asia
- Rest of World (RoW)
- Rest of World (RoW)
The report on the global neurodegenerative diseases therapeutics market covers the following areas:
- Global neurodegenerative diseases therapeutics market sizing
- Global neurodegenerative diseases therapeutics market forecast
- Global neurodegenerative diseases therapeutics market industry analysis
The report presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.
Table of Contents
1 Executive Summary
1.1 Market overview
- Executive Summary - Chart on Market Overview
- Executive Summary - Data Table on Market Overview
- Executive Summary - Chart on Global Market Characteristics
- Executive Summary - Chart on Market by Geography
- Executive Summary - Chart on Market Segmentation by Indication
- Executive Summary - Chart on Market Segmentation by Drug Class
- Executive Summary - Chart on Market Segmentation by Route of Administration
- Executive Summary - Chart on Market Segmentation by End-user
- Executive Summary - Chart on Incremental Growth
- Executive Summary - Data Table on Incremental Growth
- Executive Summary - Chart on Company Market Positioning
2 Market Analysis
2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
- Chart on Overview on criticality of inputs and factors of differentiation
- Chart on Overview on factors of disruption
- Chart on Impact of drivers and challenges in 2025 and 2030
3 Market Landscape
3.1 Market ecosystem
- Chart on Parent Market
- Data Table on - Parent Market
- Chart on Market characteristics analysis
- Chart on Value chain analysis
4 Market Sizing
4.1 Market definition
4.4 Market outlook: Forecast for 2025-2030
- Data Table on Offerings of companies included in the market definition
- Market segments
4.4 Market outlook: Forecast for 2025-2030
- Chart on Global - Market size and forecast 2025-2030 ($ million)
- Data Table on Global - Market size and forecast 2025-2030 ($ million)
- Chart on Global Market: Year-over-year growth 2025-2030 (%)
- Data Table on Global Market: Year-over-year growth 2025-2030 (%)
5 Historic Market Size
5.1 Global Neurodegenerative Diseases Therapeutics Market 2020 - 2024
- Historic Market Size - Data Table on Global Neurodegenerative Diseases Therapeutics Market 2020 - 2024 ($ million)
- Historic Market Size - Indication Segment 2020 - 2024 ($ million)
- Historic Market Size - Drug Class Segment 2020 - 2024 ($ million)
- Historic Market Size - Route of Administration Segment 2020 - 2024 ($ million)
- Historic Market Size - End-user Segment 2020 - 2024 ($ million)
- Historic Market Size - Geography Segment 2020 - 2024 ($ million)
- Historic Market Size - Country Segment 2020 - 2024 ($ million)
6 Qualitative Analysis
6.1 Impact of AI on Global Neurodegenerative Diseases Therapeutics Market
6.2 Impact of geopolitical conflicts on Global Neurodegenerative Diseases Therapeutics Market
6.2 Impact of geopolitical conflicts on Global Neurodegenerative Diseases Therapeutics Market
7 Five Forces Analysis
7.1 Five forces summary
- Five forces analysis - Comparison between 2025 and 2030
- Bargaining power of buyers - Impact of key factors 2025 and 2030
- Bargaining power of suppliers - Impact of key factors in 2025 and 2030
- Threat of new entrants - Impact of key factors in 2025 and 2030
- Threat of substitutes - Impact of key factors in 2025 and 2030
- Threat of rivalry - Impact of key factors in 2025 and 2030
- Chart on Market condition - Five forces 2025 and 2030
8 Market Segmentation by Indication
8.1 Market segments
- Chart on Indication - Market share 2025-2030 (%)
- Data Table on Indication - Market share 2025-2030 (%)
- Chart on Comparison by Indication
- Data Table on Comparison by Indication
- Chart on Multiple sclerosis - Market size and forecast 2025-2030 ($ million)
- Data Table on Multiple sclerosis - Market size and forecast 2025-2030 ($ million)
- Chart on Multiple sclerosis - Year-over-year growth 2025-2030 (%)
- Data Table on Multiple sclerosis - Year-over-year growth 2025-2030 (%)
- Chart on Alzheimers disease - Market size and forecast 2025-2030 ($ million)
- Data Table on Alzheimers disease - Market size and forecast 2025-2030 ($ million)
- Chart on Alzheimers disease - Year-over-year growth 2025-2030 (%)
- Data Table on Alzheimers disease - Year-over-year growth 2025-2030 (%)
- Chart on Parkinsons disease - Market size and forecast 2025-2030 ($ million)
- Data Table on Parkinsons disease - Market size and forecast 2025-2030 ($ million)
- Chart on Parkinsons disease - Year-over-year growth 2025-2030 (%)
- Data Table on Parkinsons disease - Year-over-year growth 2025-2030 (%)
- Chart on Huntingtons disease - Market size and forecast 2025-2030 ($ million)
- Data Table on Huntingtons disease - Market size and forecast 2025-2030 ($ million)
- Chart on Huntingtons disease - Year-over-year growth 2025-2030 (%)
- Data Table on Huntingtons disease - Year-over-year growth 2025-2030 (%)
- Chart on Others - Market size and forecast 2025-2030 ($ million)
- Data Table on Others - Market size and forecast 2025-2030 ($ million)
- Chart on Others - Year-over-year growth 2025-2030 (%)
- Data Table on Others - Year-over-year growth 2025-2030 (%)
- Market opportunity by Indication ($ million)
- Data Table on Market opportunity by Indication ($ million)
9 Market Segmentation by Drug Class
9.1 Market segments
- Chart on Drug Class - Market share 2025-2030 (%)
- Data Table on Drug Class - Market share 2025-2030 (%)
- Chart on Comparison by Drug Class
- Data Table on Comparison by Drug Class
- Chart on Immunomodulators - Market size and forecast 2025-2030 ($ million)
- Data Table on Immunomodulators - Market size and forecast 2025-2030 ($ million)
- Chart on Immunomodulators - Year-over-year growth 2025-2030 (%)
- Data Table on Immunomodulators - Year-over-year growth 2025-2030 (%)
- Chart on Interferons - Market size and forecast 2025-2030 ($ million)
- Data Table on Interferons - Market size and forecast 2025-2030 ($ million)
- Chart on Interferons - Year-over-year growth 2025-2030 (%)
- Data Table on Interferons - Year-over-year growth 2025-2030 (%)
- Chart on Decarboxylase inhibitors - Market size and forecast 2025-2030 ($ million)
- Data Table on Decarboxylase inhibitors - Market size and forecast 2025-2030 ($ million)
- Chart on Decarboxylase inhibitors - Year-over-year growth 2025-2030 (%)
- Data Table on Decarboxylase inhibitors - Year-over-year growth 2025-2030 (%)
- Chart on Dopamine agonists - Market size and forecast 2025-2030 ($ million)
- Data Table on Dopamine agonists - Market size and forecast 2025-2030 ($ million)
- Chart on Dopamine agonists - Year-over-year growth 2025-2030 (%)
- Data Table on Dopamine agonists - Year-over-year growth 2025-2030 (%)
- Chart on Others - Market size and forecast 2025-2030 ($ million)
- Data Table on Others - Market size and forecast 2025-2030 ($ million)
- Chart on Others - Year-over-year growth 2025-2030 (%)
- Data Table on Others - Year-over-year growth 2025-2030 (%)
- Market opportunity by Drug Class ($ million)
- Data Table on Market opportunity by Drug Class ($ million)
10 Market Segmentation by Route of Administration
10.1 Market segments
- Chart on Route of Administration - Market share 2025-2030 (%)
- Data Table on Route of Administration - Market share 2025-2030 (%)
- Chart on Comparison by Route of Administration
- Data Table on Comparison by Route of Administration
- Chart on Oral - Market size and forecast 2025-2030 ($ million)
- Data Table on Oral - Market size and forecast 2025-2030 ($ million)
- Chart on Oral - Year-over-year growth 2025-2030 (%)
- Data Table on Oral - Year-over-year growth 2025-2030 (%)
- Chart on Injection - Market size and forecast 2025-2030 ($ million)
- Data Table on Injection - Market size and forecast 2025-2030 ($ million)
- Chart on Injection - Year-over-year growth 2025-2030 (%)
- Data Table on Injection - Year-over-year growth 2025-2030 (%)
- Chart on Transdermal - Market size and forecast 2025-2030 ($ million)
- Data Table on Transdermal - Market size and forecast 2025-2030 ($ million)
- Chart on Transdermal - Year-over-year growth 2025-2030 (%)
- Data Table on Transdermal - Year-over-year growth 2025-2030 (%)
- Market opportunity by Route of Administration ($ million)
- Data Table on Market opportunity by Route of Administration ($ million)
11 Market Segmentation by End-user
11.1 Market segments
- Chart on End-user - Market share 2025-2030 (%)
- Data Table on End-user - Market share 2025-2030 (%)
- Chart on Comparison by End-user
- Data Table on Comparison by End-user
- Chart on Hospital pharmacy - Market size and forecast 2025-2030 ($ million)
- Data Table on Hospital pharmacy - Market size and forecast 2025-2030 ($ million)
- Chart on Hospital pharmacy - Year-over-year growth 2025-2030 (%)
- Data Table on Hospital pharmacy - Year-over-year growth 2025-2030 (%)
- Chart on Retail pharmacy - Market size and forecast 2025-2030 ($ million)
- Data Table on Retail pharmacy - Market size and forecast 2025-2030 ($ million)
- Chart on Retail pharmacy - Year-over-year growth 2025-2030 (%)
- Data Table on Retail pharmacy - Year-over-year growth 2025-2030 (%)
- Chart on Online pharmacy - Market size and forecast 2025-2030 ($ million)
- Data Table on Online pharmacy - Market size and forecast 2025-2030 ($ million)
- Chart on Online pharmacy - Year-over-year growth 2025-2030 (%)
- Data Table on Online pharmacy - Year-over-year growth 2025-2030 (%)
- Market opportunity by End-user ($ million)
- Data Table on Market opportunity by End-user ($ million)
12 Customer Landscape
12.1 Customer landscape overview
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
13 Geographic Landscape
13.1 Geographic segmentation
- Chart on Market share by geography 2025-2030 (%)
- Data Table on Market share by geography 2025-2030 (%)
- Chart on Geographic comparison
- Data Table on Geographic comparison
- Chart on North America - Market size and forecast 2025-2030 ($ million)
- Data Table on North America - Market size and forecast 2025-2030 ($ million)
- Chart on North America - Year-over-year growth 2025-2030 (%)
- Data Table on North America - Year-over-year growth 2025-2030 (%)
- Chart on Regional Comparison - North America
- Data Table on Regional Comparison - North America
- Chart on US - Market size and forecast 2025-2030 ($ million)
- Data Table on US - Market size and forecast 2025-2030 ($ million)
- Chart on US - Year-over-year growth 2025-2030 (%)
- Data Table on US - Year-over-year growth 2025-2030 (%)
- Chart on Canada - Market size and forecast 2025-2030 ($ million)
- Data Table on Canada - Market size and forecast 2025-2030 ($ million)
- Chart on Canada - Year-over-year growth 2025-2030 (%)
- Data Table on Canada - Year-over-year growth 2025-2030 (%)
- Chart on Mexico - Market size and forecast 2025-2030 ($ million)
- Data Table on Mexico - Market size and forecast 2025-2030 ($ million)
- Chart on Mexico - Year-over-year growth 2025-2030 (%)
- Data Table on Mexico - Year-over-year growth 2025-2030 (%)
- Chart on Europe - Market size and forecast 2025-2030 ($ million)
- Data Table on Europe - Market size and forecast 2025-2030 ($ million)
- Chart on Europe - Year-over-year growth 2025-2030 (%)
- Data Table on Europe - Year-over-year growth 2025-2030 (%)
- Chart on Regional Comparison - Europe
- Data Table on Regional Comparison - Europe
- Chart on Germany - Market size and forecast 2025-2030 ($ million)
- Data Table on Germany - Market size and forecast 2025-2030 ($ million)
- Chart on Germany - Year-over-year growth 2025-2030 (%)
- Data Table on Germany - Year-over-year growth 2025-2030 (%)
- Chart on UK - Market size and forecast 2025-2030 ($ million)
- Data Table on UK - Market size and forecast 2025-2030 ($ million)
- Chart on UK - Year-over-year growth 2025-2030 (%)
- Data Table on UK - Year-over-year growth 2025-2030 (%)
- Chart on France - Market size and forecast 2025-2030 ($ million)
- Data Table on France - Market size and forecast 2025-2030 ($ million)
- Chart on France - Year-over-year growth 2025-2030 (%)
- Data Table on France - Year-over-year growth 2025-2030 (%)
- Chart on Italy - Market size and forecast 2025-2030 ($ million)
- Data Table on Italy - Market size and forecast 2025-2030 ($ million)
- Chart on Italy - Year-over-year growth 2025-2030 (%)
- Data Table on Italy - Year-over-year growth 2025-2030 (%)
- Chart on Spain - Market size and forecast 2025-2030 ($ million)
- Data Table on Spain - Market size and forecast 2025-2030 ($ million)
- Chart on Spain - Year-over-year growth 2025-2030 (%)
- Data Table on Spain - Year-over-year growth 2025-2030 (%)
- Chart on The Netherlands - Market size and forecast 2025-2030 ($ million)
- Data Table on The Netherlands - Market size and forecast 2025-2030 ($ million)
- Chart on The Netherlands - Year-over-year growth 2025-2030 (%)
- Data Table on The Netherlands - Year-over-year growth 2025-2030 (%)
- Chart on Asia - Market size and forecast 2025-2030 ($ million)
- Data Table on Asia - Market size and forecast 2025-2030 ($ million)
- Chart on Asia - Year-over-year growth 2025-2030 (%)
- Data Table on Asia - Year-over-year growth 2025-2030 (%)
- Chart on Regional Comparison - Asia
- Data Table on Regional Comparison - Asia
- Chart on China - Market size and forecast 2025-2030 ($ million)
- Data Table on China - Market size and forecast 2025-2030 ($ million)
- Chart on China - Year-over-year growth 2025-2030 (%)
- Data Table on China - Year-over-year growth 2025-2030 (%)
- Chart on Japan - Market size and forecast 2025-2030 ($ million)
- Data Table on Japan - Market size and forecast 2025-2030 ($ million)
- Chart on Japan - Year-over-year growth 2025-2030 (%)
- Data Table on Japan - Year-over-year growth 2025-2030 (%)
- Chart on India - Market size and forecast 2025-2030 ($ million)
- Data Table on India - Market size and forecast 2025-2030 ($ million)
- Chart on India - Year-over-year growth 2025-2030 (%)
- Data Table on India - Year-over-year growth 2025-2030 (%)
- Chart on South Korea - Market size and forecast 2025-2030 ($ million)
- Data Table on South Korea - Market size and forecast 2025-2030 ($ million)
- Chart on South Korea - Year-over-year growth 2025-2030 (%)
- Data Table on South Korea - Year-over-year growth 2025-2030 (%)
- Chart on Singapore - Market size and forecast 2025-2030 ($ million)
- Data Table on Singapore - Market size and forecast 2025-2030 ($ million)
- Chart on Singapore - Year-over-year growth 2025-2030 (%)
- Data Table on Singapore - Year-over-year growth 2025-2030 (%)
- Chart on Thailand - Market size and forecast 2025-2030 ($ million)
- Data Table on Thailand - Market size and forecast 2025-2030 ($ million)
- Chart on Thailand - Year-over-year growth 2025-2030 (%)
- Data Table on Thailand - Year-over-year growth 2025-2030 (%)
- Chart on Rest of World (ROW) - Market size and forecast 2025-2030 ($ million)
- Data Table on Rest of World (ROW) - Market size and forecast 2025-2030 ($ million)
- Chart on Rest of World (ROW) - Year-over-year growth 2025-2030 (%)
- Data Table on Rest of World (ROW) - Year-over-year growth 2025-2030 (%)
- Chart on Regional Comparison - Rest of World (ROW)
- Data Table on Regional Comparison - Rest of World (ROW)
- Chart on Brazil - Market size and forecast 2025-2030 ($ million)
- Data Table on Brazil - Market size and forecast 2025-2030 ($ million)
- Chart on Brazil - Year-over-year growth 2025-2030 (%)
- Data Table on Brazil - Year-over-year growth 2025-2030 (%)
- Chart on Saudi Arabia - Market size and forecast 2025-2030 ($ million)
- Data Table on Saudi Arabia - Market size and forecast 2025-2030 ($ million)
- Chart on Saudi Arabia - Year-over-year growth 2025-2030 (%)
- Data Table on Saudi Arabia - Year-over-year growth 2025-2030 (%)
- Chart on South Africa - Market size and forecast 2025-2030 ($ million)
- Data Table on South Africa - Market size and forecast 2025-2030 ($ million)
- Chart on South Africa - Year-over-year growth 2025-2030 (%)
- Data Table on South Africa - Year-over-year growth 2025-2030 (%)
- Chart on UAE - Market size and forecast 2025-2030 ($ million)
- Data Table on UAE - Market size and forecast 2025-2030 ($ million)
- Chart on UAE - Year-over-year growth 2025-2030 (%)
- Data Table on UAE - Year-over-year growth 2025-2030 (%)
- Chart on Argentina - Market size and forecast 2025-2030 ($ million)
- Data Table on Argentina - Market size and forecast 2025-2030 ($ million)
- Chart on Argentina - Year-over-year growth 2025-2030 (%)
- Data Table on Argentina - Year-over-year growth 2025-2030 (%)
- Chart on Turkey - Market size and forecast 2025-2030 ($ million)
- Data Table on Turkey - Market size and forecast 2025-2030 ($ million)
- Chart on Turkey - Year-over-year growth 2025-2030 (%)
- Data Table on Turkey - Year-over-year growth 2025-2030 (%)
- Chart on Egypt - Market size and forecast 2025-2030 ($ million)
- Data Table on Egypt - Market size and forecast 2025-2030 ($ million)
- Chart on Egypt - Year-over-year growth 2025-2030 (%)
- Data Table on Egypt - Year-over-year growth 2025-2030 (%)
- Chart on Chile - Market size and forecast 2025-2030 ($ million)
- Data Table on Chile - Market size and forecast 2025-2030 ($ million)
- Chart on Chile - Year-over-year growth 2025-2030 (%)
- Data Table on Chile - Year-over-year growth 2025-2030 (%)
- Market opportunity by geography ($ million)
- Data Tables on Market opportunity by geography ($ million)
14 Drivers, Challenges, and Opportunity
14.1 Market drivers
- Rapidly aging global demographic and rising disease prevalence
- Breakthroughs in biomarker discovery and early diagnostic technologies
- Increased funding and favorable regulatory pathways
- High attrition rates in clinical trial execution
- Prohibitive research expenditures and fragmented insurance coverage
- Strict regulatory compliance protocols and evolving safety thresholds
- Impact of drivers and challenges in 2025 and 2030
- Growing aging population and neurological disease burden
- Accelerated approvals for advanced neurotherapies
- Evolution of early detection and biomarker technologies
15 Competitive Landscape
15.1 Overview
15.2 Competitive Landscape
15.2 Competitive Landscape
- Overview on criticality of inputs and factors of differentiation
- Overview on factors of disruption
- Impact of key risks on business
16 Competitive Analysis
16.1 Companies profiled
- Companies covered
- Company ranking index
- Matrix on companies position and classification
- AbbVie Inc. - Overview
- AbbVie Inc. - Business segments
- AbbVie Inc. - Key news
- AbbVie Inc. - Key offerings
- AbbVie Inc. - Segment focus
- SWOT
- Acadia Pharmaceuticals Inc. - Overview
- Acadia Pharmaceuticals Inc. - Product / Service
- Acadia Pharmaceuticals Inc. - Key offerings
- SWOT
- Amneal Pharmaceuticals Inc. - Overview
- Amneal Pharmaceuticals Inc. - Business segments
- Amneal Pharmaceuticals Inc. - Key offerings
- Amneal Pharmaceuticals Inc. - Segment focus
- SWOT
- Bayer AG - Overview
- Bayer AG - Business segments
- Bayer AG - Key offerings
- Bayer AG - Segment focus
- SWOT
- Biogen Inc. - Overview
- Biogen Inc. - Product / Service
- Biogen Inc. - Key offerings
- SWOT
- Bristol Myers Squibb Co. - Overview
- Bristol Myers Squibb Co. - Product / Service
- Bristol Myers Squibb Co. - Key news
- Bristol Myers Squibb Co. - Key offerings
- SWOT
- Dr. Reddys Laboratories Ltd. - Overview
- Dr. Reddys Laboratories Ltd. - Business segments
- Dr. Reddys Laboratories Ltd. - Key news
- Dr. Reddys Laboratories Ltd. - Key offerings
- Dr. Reddys Laboratories Ltd. - Segment focus
- SWOT
- Eisai Co. Ltd. - Overview
- Eisai Co. Ltd. - Business segments
- Eisai Co. Ltd. - Key offerings
- Eisai Co. Ltd. - Segment focus
- SWOT
- Eli Lilly and Co. - Overview
- Eli Lilly and Co. - Product / Service
- Eli Lilly and Co. - Key offerings
- SWOT
- F. Hoffmann La Roche Ltd. - Overview
- F. Hoffmann La Roche Ltd. - Business segments
- F. Hoffmann La Roche Ltd. - Key news
- F. Hoffmann La Roche Ltd. - Key offerings
- F. Hoffmann La Roche Ltd. - Segment focus
- SWOT
- GlaxoSmithKline Plc - Overview
- GlaxoSmithKline Plc - Business segments
- GlaxoSmithKline Plc - Key news
- GlaxoSmithKline Plc - Key offerings
- GlaxoSmithKline Plc - Segment focus
- SWOT
- Johnson and Johnson - Overview
- Johnson and Johnson - Business segments
- Johnson and Johnson - Key news
- Johnson and Johnson - Key offerings
- Johnson and Johnson - Segment focus
- SWOT
- Merck KGaA - Overview
- Merck KGaA - Business segments
- Merck KGaA - Key news
- Merck KGaA - Key offerings
- Merck KGaA - Segment focus
- SWOT
- Novartis AG - Overview
- Novartis AG - Business segments
- Novartis AG - Key news
- Novartis AG - Key offerings
- Novartis AG - Segment focus
- SWOT
- Pfizer Inc. - Overview
- Pfizer Inc. - Business segments
- Pfizer Inc. - Key news
- Pfizer Inc. - Key offerings
- Pfizer Inc. - Segment focus
- SWOT
17 Appendix
17.1 Scope of the report
- Market definition
- Objectives
- Notes and caveats
- Inclusions checklist
- Exclusions checklist
- Currency conversion rates for US$
- Research methodology
- Information sources
- Data validation
- Validation techniques employed for market sizing
- Data synthesis
- 360 degree market analysis
- List of abbreviations
List of Exhibits
Exhibit 1: Executive Summary - Chart on Market Overview
Exhibit 2: Executive Summary - Data Table on Market Overview
Exhibit 3: Executive Summary - Chart on Global Market Characteristics
Exhibit 4: Executive Summary - Chart on Market by Geography
Exhibit 5: Executive Summary - Chart on Market Segmentation by Indication
Exhibit 6: Executive Summary - Chart on Market Segmentation by Drug Class
Exhibit 7: Executive Summary - Chart on Market Segmentation by Route of Administration
Exhibit 8: Executive Summary - Chart on Market Segmentation by End-user
Exhibit 9: Executive Summary - Chart on Incremental Growth
Exhibit 10: Executive Summary - Data Table on Incremental Growth
Exhibit 11: Executive Summary - Chart on Company Market Positioning
Exhibit 12: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibit 13: Chart on Overview on criticality of inputs and factors of differentiation
Exhibit 14: Chart on Overview on factors of disruption
Exhibit 15: Chart on Impact of drivers and challenges in 2025 and 2030
Exhibit 16: Chart on Parent Market
Exhibit 17: Data Table on - Parent Market
Exhibit 18: Chart on Market characteristics analysis
Exhibit 19: Chart on Value chain analysis
Exhibit 20: Data Table on Offerings of companies included in the market definition
Exhibit 21: Market segments
Exhibit 22: Chart on Global - Market size and forecast 2025-2030 ($ million)
Exhibit 23: Data Table on Global - Market size and forecast 2025-2030 ($ million)
Exhibit 24: Chart on Global Market: Year-over-year growth 2025-2030 (%)
Exhibit 25: Data Table on Global Market: Year-over-year growth 2025-2030 (%)
Exhibit 26: Historic Market Size - Data Table on Global Neurodegenerative Diseases Therapeutics Market 2020 - 2024 ($ million)
Exhibit 27: Historic Market Size - Indication Segment 2020 - 2024 ($ million)
Exhibit 28: Historic Market Size - Drug Class Segment 2020 - 2024 ($ million)
Exhibit 29: Historic Market Size - Route of Administration Segment 2020 - 2024 ($ million)
Exhibit 30: Historic Market Size - End-user Segment 2020 - 2024 ($ million)
Exhibit 31: Historic Market Size - Geography Segment 2020 - 2024 ($ million)
Exhibit 32: Historic Market Size - Country Segment 2020 - 2024 ($ million)
Exhibit 33: Five forces analysis - Comparison between 2025 and 2030
Exhibit 34: Bargaining power of buyers - Impact of key factors 2025 and 2030
Exhibit 35: Bargaining power of suppliers - Impact of key factors in 2025 and 2030
Exhibit 36: Threat of new entrants - Impact of key factors in 2025 and 2030
Exhibit 37: Threat of substitutes - Impact of key factors in 2025 and 2030
Exhibit 38: Threat of rivalry - Impact of key factors in 2025 and 2030
Exhibit 39: Chart on Market condition - Five forces 2025 and 2030
Exhibit 40: Chart on Indication - Market share 2025-2030 (%)
Exhibit 41: Data Table on Indication - Market share 2025-2030 (%)
Exhibit 42: Chart on Comparison by Indication
Exhibit 43: Data Table on Comparison by Indication
Exhibit 44: Chart on Multiple sclerosis - Market size and forecast 2025-2030 ($ million)
Exhibit 45: Data Table on Multiple sclerosis - Market size and forecast 2025-2030 ($ million)
Exhibit 46: Chart on Multiple sclerosis - Year-over-year growth 2025-2030 (%)
Exhibit 47: Data Table on Multiple sclerosis - Year-over-year growth 2025-2030 (%)
Exhibit 48: Chart on Alzheimers disease - Market size and forecast 2025-2030 ($ million)
Exhibit 49: Data Table on Alzheimers disease - Market size and forecast 2025-2030 ($ million)
Exhibit 50: Chart on Alzheimers disease - Year-over-year growth 2025-2030 (%)
Exhibit 51: Data Table on Alzheimers disease - Year-over-year growth 2025-2030 (%)
Exhibit 52: Chart on Parkinsons disease - Market size and forecast 2025-2030 ($ million)
Exhibit 53: Data Table on Parkinsons disease - Market size and forecast 2025-2030 ($ million)
Exhibit 54: Chart on Parkinsons disease - Year-over-year growth 2025-2030 (%)
Exhibit 55: Data Table on Parkinsons disease - Year-over-year growth 2025-2030 (%)
Exhibit 56: Chart on Huntingtons disease - Market size and forecast 2025-2030 ($ million)
Exhibit 57: Data Table on Huntingtons disease - Market size and forecast 2025-2030 ($ million)
Exhibit 58: Chart on Huntingtons disease - Year-over-year growth 2025-2030 (%)
Exhibit 59: Data Table on Huntingtons disease - Year-over-year growth 2025-2030 (%)
Exhibit 60: Chart on Others - Market size and forecast 2025-2030 ($ million)
Exhibit 61: Data Table on Others - Market size and forecast 2025-2030 ($ million)
Exhibit 62: Chart on Others - Year-over-year growth 2025-2030 (%)
Exhibit 63: Data Table on Others - Year-over-year growth 2025-2030 (%)
Exhibit 64: Market opportunity by Indication ($ million)
Exhibit 65: Data Table on Market opportunity by Indication ($ million)
Exhibit 66: Chart on Drug Class - Market share 2025-2030 (%)
Exhibit 67: Data Table on Drug Class - Market share 2025-2030 (%)
Exhibit 68: Chart on Comparison by Drug Class
Exhibit 69: Data Table on Comparison by Drug Class
Exhibit 70: Chart on Immunomodulators - Market size and forecast 2025-2030 ($ million)
Exhibit 71: Data Table on Immunomodulators - Market size and forecast 2025-2030 ($ million)
Exhibit 72: Chart on Immunomodulators - Year-over-year growth 2025-2030 (%)
Exhibit 73: Data Table on Immunomodulators - Year-over-year growth 2025-2030 (%)
Exhibit 74: Chart on Interferons - Market size and forecast 2025-2030 ($ million)
Exhibit 75: Data Table on Interferons - Market size and forecast 2025-2030 ($ million)
Exhibit 76: Chart on Interferons - Year-over-year growth 2025-2030 (%)
Exhibit 77: Data Table on Interferons - Year-over-year growth 2025-2030 (%)
Exhibit 78: Chart on Decarboxylase inhibitors - Market size and forecast 2025-2030 ($ million)
Exhibit 79: Data Table on Decarboxylase inhibitors - Market size and forecast 2025-2030 ($ million)
Exhibit 80: Chart on Decarboxylase inhibitors - Year-over-year growth 2025-2030 (%)
Exhibit 81: Data Table on Decarboxylase inhibitors - Year-over-year growth 2025-2030 (%)
Exhibit 82: Chart on Dopamine agonists - Market size and forecast 2025-2030 ($ million)
Exhibit 83: Data Table on Dopamine agonists - Market size and forecast 2025-2030 ($ million)
Exhibit 84: Chart on Dopamine agonists - Year-over-year growth 2025-2030 (%)
Exhibit 85: Data Table on Dopamine agonists - Year-over-year growth 2025-2030 (%)
Exhibit 86: Chart on Others - Market size and forecast 2025-2030 ($ million)
Exhibit 87: Data Table on Others - Market size and forecast 2025-2030 ($ million)
Exhibit 88: Chart on Others - Year-over-year growth 2025-2030 (%)
Exhibit 89: Data Table on Others - Year-over-year growth 2025-2030 (%)
Exhibit 90: Market opportunity by Drug Class ($ million)
Exhibit 91: Data Table on Market opportunity by Drug Class ($ million)
Exhibit 92: Chart on Route of Administration - Market share 2025-2030 (%)
Exhibit 93: Data Table on Route of Administration - Market share 2025-2030 (%)
Exhibit 94: Chart on Comparison by Route of Administration
Exhibit 95: Data Table on Comparison by Route of Administration
Exhibit 96: Chart on Oral - Market size and forecast 2025-2030 ($ million)
Exhibit 97: Data Table on Oral - Market size and forecast 2025-2030 ($ million)
Exhibit 98: Chart on Oral - Year-over-year growth 2025-2030 (%)
Exhibit 99: Data Table on Oral - Year-over-year growth 2025-2030 (%)
Exhibit 100: Chart on Injection - Market size and forecast 2025-2030 ($ million)
Exhibit 101: Data Table on Injection - Market size and forecast 2025-2030 ($ million)
Exhibit 102: Chart on Injection - Year-over-year growth 2025-2030 (%)
Exhibit 103: Data Table on Injection - Year-over-year growth 2025-2030 (%)
Exhibit 104: Chart on Transdermal - Market size and forecast 2025-2030 ($ million)
Exhibit 105: Data Table on Transdermal - Market size and forecast 2025-2030 ($ million)
Exhibit 106: Chart on Transdermal - Year-over-year growth 2025-2030 (%)
Exhibit 107: Data Table on Transdermal - Year-over-year growth 2025-2030 (%)
Exhibit 108: Market opportunity by Route of Administration ($ million)
Exhibit 109: Data Table on Market opportunity by Route of Administration ($ million)
Exhibit 110: Chart on End-user - Market share 2025-2030 (%)
Exhibit 111: Data Table on End-user - Market share 2025-2030 (%)
Exhibit 112: Chart on Comparison by End-user
Exhibit 113: Data Table on Comparison by End-user
Exhibit 114: Chart on Hospital pharmacy - Market size and forecast 2025-2030 ($ million)
Exhibit 115: Data Table on Hospital pharmacy - Market size and forecast 2025-2030 ($ million)
Exhibit 116: Chart on Hospital pharmacy - Year-over-year growth 2025-2030 (%)
Exhibit 117: Data Table on Hospital pharmacy - Year-over-year growth 2025-2030 (%)
Exhibit 118: Chart on Retail pharmacy - Market size and forecast 2025-2030 ($ million)
Exhibit 119: Data Table on Retail pharmacy - Market size and forecast 2025-2030 ($ million)
Exhibit 120: Chart on Retail pharmacy - Year-over-year growth 2025-2030 (%)
Exhibit 121: Data Table on Retail pharmacy - Year-over-year growth 2025-2030 (%)
Exhibit 122: Chart on Online pharmacy - Market size and forecast 2025-2030 ($ million)
Exhibit 123: Data Table on Online pharmacy - Market size and forecast 2025-2030 ($ million)
Exhibit 124: Chart on Online pharmacy - Year-over-year growth 2025-2030 (%)
Exhibit 125: Data Table on Online pharmacy - Year-over-year growth 2025-2030 (%)
Exhibit 126: Market opportunity by End-user ($ million)
Exhibit 127: Data Table on Market opportunity by End-user ($ million)
Exhibit 128: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibit 129: Chart on Market share by geography 2025-2030 (%)
Exhibit 130: Data Table on Market share by geography 2025-2030 (%)
Exhibit 131: Chart on Geographic comparison
Exhibit 132: Data Table on Geographic comparison
Exhibit 133: Chart on North America - Market size and forecast 2025-2030 ($ million)
Exhibit 134: Data Table on North America - Market size and forecast 2025-2030 ($ million)
Exhibit 135: Chart on North America - Year-over-year growth 2025-2030 (%)
Exhibit 136: Data Table on North America - Year-over-year growth 2025-2030 (%)
Exhibit 137: Chart on Regional Comparison - North America
Exhibit 138: Data Table on Regional Comparison - North America
Exhibit 139: Chart on US - Market size and forecast 2025-2030 ($ million)
Exhibit 140: Data Table on US - Market size and forecast 2025-2030 ($ million)
Exhibit 141: Chart on US - Year-over-year growth 2025-2030 (%)
Exhibit 142: Data Table on US - Year-over-year growth 2025-2030 (%)
Exhibit 143: Chart on Canada - Market size and forecast 2025-2030 ($ million)
Exhibit 144: Data Table on Canada - Market size and forecast 2025-2030 ($ million)
Exhibit 145: Chart on Canada - Year-over-year growth 2025-2030 (%)
Exhibit 146: Data Table on Canada - Year-over-year growth 2025-2030 (%)
Exhibit 147: Chart on Mexico - Market size and forecast 2025-2030 ($ million)
Exhibit 148: Data Table on Mexico - Market size and forecast 2025-2030 ($ million)
Exhibit 149: Chart on Mexico - Year-over-year growth 2025-2030 (%)
Exhibit 150: Data Table on Mexico - Year-over-year growth 2025-2030 (%)
Exhibit 151: Chart on Europe - Market size and forecast 2025-2030 ($ million)
Exhibit 152: Data Table on Europe - Market size and forecast 2025-2030 ($ million)
Exhibit 153: Chart on Europe - Year-over-year growth 2025-2030 (%)
Exhibit 154: Data Table on Europe - Year-over-year growth 2025-2030 (%)
Exhibit 155: Chart on Regional Comparison - Europe
Exhibit 156: Data Table on Regional Comparison - Europe
Exhibit 157: Chart on Germany - Market size and forecast 2025-2030 ($ million)
Exhibit 158: Data Table on Germany - Market size and forecast 2025-2030 ($ million)
Exhibit 159: Chart on Germany - Year-over-year growth 2025-2030 (%)
Exhibit 160: Data Table on Germany - Year-over-year growth 2025-2030 (%)
Exhibit 161: Chart on UK - Market size and forecast 2025-2030 ($ million)
Exhibit 162: Data Table on UK - Market size and forecast 2025-2030 ($ million)
Exhibit 163: Chart on UK - Year-over-year growth 2025-2030 (%)
Exhibit 164: Data Table on UK - Year-over-year growth 2025-2030 (%)
Exhibit 165: Chart on France - Market size and forecast 2025-2030 ($ million)
Exhibit 166: Data Table on France - Market size and forecast 2025-2030 ($ million)
Exhibit 167: Chart on France - Year-over-year growth 2025-2030 (%)
Exhibit 168: Data Table on France - Year-over-year growth 2025-2030 (%)
Exhibit 169: Chart on Italy - Market size and forecast 2025-2030 ($ million)
Exhibit 170: Data Table on Italy - Market size and forecast 2025-2030 ($ million)
Exhibit 171: Chart on Italy - Year-over-year growth 2025-2030 (%)
Exhibit 172: Data Table on Italy - Year-over-year growth 2025-2030 (%)
Exhibit 173: Chart on Spain - Market size and forecast 2025-2030 ($ million)
Exhibit 174: Data Table on Spain - Market size and forecast 2025-2030 ($ million)
Exhibit 175: Chart on Spain - Year-over-year growth 2025-2030 (%)
Exhibit 176: Data Table on Spain - Year-over-year growth 2025-2030 (%)
Exhibit 177: Chart on The Netherlands - Market size and forecast 2025-2030 ($ million)
Exhibit 178: Data Table on The Netherlands - Market size and forecast 2025-2030 ($ million)
Exhibit 179: Chart on The Netherlands - Year-over-year growth 2025-2030 (%)
Exhibit 180: Data Table on The Netherlands - Year-over-year growth 2025-2030 (%)
Exhibit 181: Chart on Asia - Market size and forecast 2025-2030 ($ million)
Exhibit 182: Data Table on Asia - Market size and forecast 2025-2030 ($ million)
Exhibit 183: Chart on Asia - Year-over-year growth 2025-2030 (%)
Exhibit 184: Data Table on Asia - Year-over-year growth 2025-2030 (%)
Exhibit 185: Chart on Regional Comparison - Asia
Exhibit 186: Data Table on Regional Comparison - Asia
Exhibit 187: Chart on China - Market size and forecast 2025-2030 ($ million)
Exhibit 188: Data Table on China - Market size and forecast 2025-2030 ($ million)
Exhibit 189: Chart on China - Year-over-year growth 2025-2030 (%)
Exhibit 190: Data Table on China - Year-over-year growth 2025-2030 (%)
Exhibit 191: Chart on Japan - Market size and forecast 2025-2030 ($ million)
Exhibit 192: Data Table on Japan - Market size and forecast 2025-2030 ($ million)
Exhibit 193: Chart on Japan - Year-over-year growth 2025-2030 (%)
Exhibit 194: Data Table on Japan - Year-over-year growth 2025-2030 (%)
Exhibit 195: Chart on India - Market size and forecast 2025-2030 ($ million)
Exhibit 196: Data Table on India - Market size and forecast 2025-2030 ($ million)
Exhibit 197: Chart on India - Year-over-year growth 2025-2030 (%)
Exhibit 198: Data Table on India - Year-over-year growth 2025-2030 (%)
Exhibit 199: Chart on South Korea - Market size and forecast 2025-2030 ($ million)
Exhibit 200: Data Table on South Korea - Market size and forecast 2025-2030 ($ million)
Exhibit 201: Chart on South Korea - Year-over-year growth 2025-2030 (%)
Exhibit 202: Data Table on South Korea - Year-over-year growth 2025-2030 (%)
Exhibit 203: Chart on Singapore - Market size and forecast 2025-2030 ($ million)
Exhibit 204: Data Table on Singapore - Market size and forecast 2025-2030 ($ million)
Exhibit 205: Chart on Singapore - Year-over-year growth 2025-2030 (%)
Exhibit 206: Data Table on Singapore - Year-over-year growth 2025-2030 (%)
Exhibit 207: Chart on Thailand - Market size and forecast 2025-2030 ($ million)
Exhibit 208: Data Table on Thailand - Market size and forecast 2025-2030 ($ million)
Exhibit 209: Chart on Thailand - Year-over-year growth 2025-2030 (%)
Exhibit 210: Data Table on Thailand - Year-over-year growth 2025-2030 (%)
Exhibit 211: Chart on Rest of World (ROW) - Market size and forecast 2025-2030 ($ million)
Exhibit 212: Data Table on Rest of World (ROW) - Market size and forecast 2025-2030 ($ million)
Exhibit 213: Chart on Rest of World (ROW) - Year-over-year growth 2025-2030 (%)
Exhibit 214: Data Table on Rest of World (ROW) - Year-over-year growth 2025-2030 (%)
Exhibit 215: Chart on Regional Comparison - Rest of World (ROW)
Exhibit 216: Data Table on Regional Comparison - Rest of World (ROW)
Exhibit 217: Chart on Brazil - Market size and forecast 2025-2030 ($ million)
Exhibit 218: Data Table on Brazil - Market size and forecast 2025-2030 ($ million)
Exhibit 219: Chart on Brazil - Year-over-year growth 2025-2030 (%)
Exhibit 220: Data Table on Brazil - Year-over-year growth 2025-2030 (%)
Exhibit 221: Chart on Saudi Arabia - Market size and forecast 2025-2030 ($ million)
Exhibit 222: Data Table on Saudi Arabia - Market size and forecast 2025-2030 ($ million)
Exhibit 223: Chart on Saudi Arabia - Year-over-year growth 2025-2030 (%)
Exhibit 224: Data Table on Saudi Arabia - Year-over-year growth 2025-2030 (%)
Exhibit 225: Chart on South Africa - Market size and forecast 2025-2030 ($ million)
Exhibit 226: Data Table on South Africa - Market size and forecast 2025-2030 ($ million)
Exhibit 227: Chart on South Africa - Year-over-year growth 2025-2030 (%)
Exhibit 228: Data Table on South Africa - Year-over-year growth 2025-2030 (%)
Exhibit 229: Chart on UAE - Market size and forecast 2025-2030 ($ million)
Exhibit 230: Data Table on UAE - Market size and forecast 2025-2030 ($ million)
Exhibit 231: Chart on UAE - Year-over-year growth 2025-2030 (%)
Exhibit 232: Data Table on UAE - Year-over-year growth 2025-2030 (%)
Exhibit 233: Chart on Argentina - Market size and forecast 2025-2030 ($ million)
Exhibit 234: Data Table on Argentina - Market size and forecast 2025-2030 ($ million)
Exhibit 235: Chart on Argentina - Year-over-year growth 2025-2030 (%)
Exhibit 236: Data Table on Argentina - Year-over-year growth 2025-2030 (%)
Exhibit 237: Chart on Turkey - Market size and forecast 2025-2030 ($ million)
Exhibit 238: Data Table on Turkey - Market size and forecast 2025-2030 ($ million)
Exhibit 239: Chart on Turkey - Year-over-year growth 2025-2030 (%)
Exhibit 240: Data Table on Turkey - Year-over-year growth 2025-2030 (%)
Exhibit 241: Chart on Egypt - Market size and forecast 2025-2030 ($ million)
Exhibit 242: Data Table on Egypt - Market size and forecast 2025-2030 ($ million)
Exhibit 243: Chart on Egypt - Year-over-year growth 2025-2030 (%)
Exhibit 244: Data Table on Egypt - Year-over-year growth 2025-2030 (%)
Exhibit 245: Chart on Chile - Market size and forecast 2025-2030 ($ million)
Exhibit 246: Data Table on Chile - Market size and forecast 2025-2030 ($ million)
Exhibit 247: Chart on Chile - Year-over-year growth 2025-2030 (%)
Exhibit 248: Data Table on Chile - Year-over-year growth 2025-2030 (%)
Exhibit 249: Market opportunity by geography ($ million)
Exhibit 250: Data Tables on Market opportunity by geography ($ million)
Exhibit 251: Impact of drivers and challenges in 2025 and 2030
Exhibit 252: Overview on criticality of inputs and factors of differentiation
Exhibit 253: Overview on factors of disruption
Exhibit 254: Impact of key risks on business
Exhibit 255: Companies covered
Exhibit 256: Company ranking index
Exhibit 257: Matrix on companies position and classification
Exhibit 258: AbbVie Inc. - Overview
Exhibit 259: AbbVie Inc. - Business segments
Exhibit 260: AbbVie Inc. - Key news
Exhibit 261: AbbVie Inc. - Key offerings
Exhibit 262: AbbVie Inc. - Segment focus
Exhibit 263: SWOT
Exhibit 264: Acadia Pharmaceuticals Inc. - Overview
Exhibit 265: Acadia Pharmaceuticals Inc. - Product / Service
Exhibit 266: Acadia Pharmaceuticals Inc. - Key offerings
Exhibit 267: SWOT
Exhibit 268: Amneal Pharmaceuticals Inc. - Overview
Exhibit 269: Amneal Pharmaceuticals Inc. - Business segments
Exhibit 270: Amneal Pharmaceuticals Inc. - Key offerings
Exhibit 271: Amneal Pharmaceuticals Inc. - Segment focus
Exhibit 272: SWOT
Exhibit 273: Bayer AG - Overview
Exhibit 274: Bayer AG - Business segments
Exhibit 275: Bayer AG - Key offerings
Exhibit 276: Bayer AG - Segment focus
Exhibit 277: SWOT
Exhibit 278: Biogen Inc. - Overview
Exhibit 279: Biogen Inc. - Product / Service
Exhibit 280: Biogen Inc. - Key offerings
Exhibit 281: SWOT
Exhibit 282: Bristol Myers Squibb Co. - Overview
Exhibit 283: Bristol Myers Squibb Co. - Product / Service
Exhibit 284: Bristol Myers Squibb Co. - Key news
Exhibit 285: Bristol Myers Squibb Co. - Key offerings
Exhibit 286: SWOT
Exhibit 287: Dr. Reddys Laboratories Ltd. - Overview
Exhibit 288: Dr. Reddys Laboratories Ltd. - Business segments
Exhibit 289: Dr. Reddys Laboratories Ltd. - Key news
Exhibit 290: Dr. Reddys Laboratories Ltd. - Key offerings
Exhibit 291: Dr. Reddys Laboratories Ltd. - Segment focus
Exhibit 292: SWOT
Exhibit 293: Eisai Co. Ltd. - Overview
Exhibit 294: Eisai Co. Ltd. - Business segments
Exhibit 295: Eisai Co. Ltd. - Key offerings
Exhibit 296: Eisai Co. Ltd. - Segment focus
Exhibit 297: SWOT
Exhibit 298: Eli Lilly and Co. - Overview
Exhibit 299: Eli Lilly and Co. - Product / Service
Exhibit 300: Eli Lilly and Co. - Key offerings
Exhibit 301: SWOT
Exhibit 302: F. Hoffmann La Roche Ltd. - Overview
Exhibit 303: F. Hoffmann La Roche Ltd. - Business segments
Exhibit 304: F. Hoffmann La Roche Ltd. - Key news
Exhibit 305: F. Hoffmann La Roche Ltd. - Key offerings
Exhibit 306: F. Hoffmann La Roche Ltd. - Segment focus
Exhibit 307: SWOT
Exhibit 308: GlaxoSmithKline Plc - Overview
Exhibit 309: GlaxoSmithKline Plc - Business segments
Exhibit 310: GlaxoSmithKline Plc - Key news
Exhibit 311: GlaxoSmithKline Plc - Key offerings
Exhibit 312: GlaxoSmithKline Plc - Segment focus
Exhibit 313: SWOT
Exhibit 314: Johnson and Johnson - Overview
Exhibit 315: Johnson and Johnson - Business segments
Exhibit 316: Johnson and Johnson - Key news
Exhibit 317: Johnson and Johnson - Key offerings
Exhibit 318: Johnson and Johnson - Segment focus
Exhibit 319: SWOT
Exhibit 320: Merck KGaA - Overview
Exhibit 321: Merck KGaA - Business segments
Exhibit 322: Merck KGaA - Key news
Exhibit 323: Merck KGaA - Key offerings
Exhibit 324: Merck KGaA - Segment focus
Exhibit 325: SWOT
Exhibit 326: Novartis AG - Overview
Exhibit 327: Novartis AG - Business segments
Exhibit 328: Novartis AG - Key news
Exhibit 329: Novartis AG - Key offerings
Exhibit 330: Novartis AG - Segment focus
Exhibit 331: SWOT
Exhibit 332: Pfizer Inc. - Overview
Exhibit 333: Pfizer Inc. - Business segments
Exhibit 334: Pfizer Inc. - Key news
Exhibit 335: Pfizer Inc. - Key offerings
Exhibit 336: Pfizer Inc. - Segment focus
Exhibit 337: SWOT
Exhibit 338: Inclusions checklist
Exhibit 339: Exclusions checklist
Exhibit 340: Currency conversion rates for US$
Exhibit 341: Research methodology
Exhibit 342: Information sources
Exhibit 343: Data validation
Exhibit 344: Validation techniques employed for market sizing
Exhibit 345: Data synthesis
Exhibit 346: 360 degree market analysis
Exhibit 347: List of abbreviations
Exhibit 2: Executive Summary - Data Table on Market Overview
Exhibit 3: Executive Summary - Chart on Global Market Characteristics
Exhibit 4: Executive Summary - Chart on Market by Geography
Exhibit 5: Executive Summary - Chart on Market Segmentation by Indication
Exhibit 6: Executive Summary - Chart on Market Segmentation by Drug Class
Exhibit 7: Executive Summary - Chart on Market Segmentation by Route of Administration
Exhibit 8: Executive Summary - Chart on Market Segmentation by End-user
Exhibit 9: Executive Summary - Chart on Incremental Growth
Exhibit 10: Executive Summary - Data Table on Incremental Growth
Exhibit 11: Executive Summary - Chart on Company Market Positioning
Exhibit 12: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibit 13: Chart on Overview on criticality of inputs and factors of differentiation
Exhibit 14: Chart on Overview on factors of disruption
Exhibit 15: Chart on Impact of drivers and challenges in 2025 and 2030
Exhibit 16: Chart on Parent Market
Exhibit 17: Data Table on - Parent Market
Exhibit 18: Chart on Market characteristics analysis
Exhibit 19: Chart on Value chain analysis
Exhibit 20: Data Table on Offerings of companies included in the market definition
Exhibit 21: Market segments
Exhibit 22: Chart on Global - Market size and forecast 2025-2030 ($ million)
Exhibit 23: Data Table on Global - Market size and forecast 2025-2030 ($ million)
Exhibit 24: Chart on Global Market: Year-over-year growth 2025-2030 (%)
Exhibit 25: Data Table on Global Market: Year-over-year growth 2025-2030 (%)
Exhibit 26: Historic Market Size - Data Table on Global Neurodegenerative Diseases Therapeutics Market 2020 - 2024 ($ million)
Exhibit 27: Historic Market Size - Indication Segment 2020 - 2024 ($ million)
Exhibit 28: Historic Market Size - Drug Class Segment 2020 - 2024 ($ million)
Exhibit 29: Historic Market Size - Route of Administration Segment 2020 - 2024 ($ million)
Exhibit 30: Historic Market Size - End-user Segment 2020 - 2024 ($ million)
Exhibit 31: Historic Market Size - Geography Segment 2020 - 2024 ($ million)
Exhibit 32: Historic Market Size - Country Segment 2020 - 2024 ($ million)
Exhibit 33: Five forces analysis - Comparison between 2025 and 2030
Exhibit 34: Bargaining power of buyers - Impact of key factors 2025 and 2030
Exhibit 35: Bargaining power of suppliers - Impact of key factors in 2025 and 2030
Exhibit 36: Threat of new entrants - Impact of key factors in 2025 and 2030
Exhibit 37: Threat of substitutes - Impact of key factors in 2025 and 2030
Exhibit 38: Threat of rivalry - Impact of key factors in 2025 and 2030
Exhibit 39: Chart on Market condition - Five forces 2025 and 2030
Exhibit 40: Chart on Indication - Market share 2025-2030 (%)
Exhibit 41: Data Table on Indication - Market share 2025-2030 (%)
Exhibit 42: Chart on Comparison by Indication
Exhibit 43: Data Table on Comparison by Indication
Exhibit 44: Chart on Multiple sclerosis - Market size and forecast 2025-2030 ($ million)
Exhibit 45: Data Table on Multiple sclerosis - Market size and forecast 2025-2030 ($ million)
Exhibit 46: Chart on Multiple sclerosis - Year-over-year growth 2025-2030 (%)
Exhibit 47: Data Table on Multiple sclerosis - Year-over-year growth 2025-2030 (%)
Exhibit 48: Chart on Alzheimers disease - Market size and forecast 2025-2030 ($ million)
Exhibit 49: Data Table on Alzheimers disease - Market size and forecast 2025-2030 ($ million)
Exhibit 50: Chart on Alzheimers disease - Year-over-year growth 2025-2030 (%)
Exhibit 51: Data Table on Alzheimers disease - Year-over-year growth 2025-2030 (%)
Exhibit 52: Chart on Parkinsons disease - Market size and forecast 2025-2030 ($ million)
Exhibit 53: Data Table on Parkinsons disease - Market size and forecast 2025-2030 ($ million)
Exhibit 54: Chart on Parkinsons disease - Year-over-year growth 2025-2030 (%)
Exhibit 55: Data Table on Parkinsons disease - Year-over-year growth 2025-2030 (%)
Exhibit 56: Chart on Huntingtons disease - Market size and forecast 2025-2030 ($ million)
Exhibit 57: Data Table on Huntingtons disease - Market size and forecast 2025-2030 ($ million)
Exhibit 58: Chart on Huntingtons disease - Year-over-year growth 2025-2030 (%)
Exhibit 59: Data Table on Huntingtons disease - Year-over-year growth 2025-2030 (%)
Exhibit 60: Chart on Others - Market size and forecast 2025-2030 ($ million)
Exhibit 61: Data Table on Others - Market size and forecast 2025-2030 ($ million)
Exhibit 62: Chart on Others - Year-over-year growth 2025-2030 (%)
Exhibit 63: Data Table on Others - Year-over-year growth 2025-2030 (%)
Exhibit 64: Market opportunity by Indication ($ million)
Exhibit 65: Data Table on Market opportunity by Indication ($ million)
Exhibit 66: Chart on Drug Class - Market share 2025-2030 (%)
Exhibit 67: Data Table on Drug Class - Market share 2025-2030 (%)
Exhibit 68: Chart on Comparison by Drug Class
Exhibit 69: Data Table on Comparison by Drug Class
Exhibit 70: Chart on Immunomodulators - Market size and forecast 2025-2030 ($ million)
Exhibit 71: Data Table on Immunomodulators - Market size and forecast 2025-2030 ($ million)
Exhibit 72: Chart on Immunomodulators - Year-over-year growth 2025-2030 (%)
Exhibit 73: Data Table on Immunomodulators - Year-over-year growth 2025-2030 (%)
Exhibit 74: Chart on Interferons - Market size and forecast 2025-2030 ($ million)
Exhibit 75: Data Table on Interferons - Market size and forecast 2025-2030 ($ million)
Exhibit 76: Chart on Interferons - Year-over-year growth 2025-2030 (%)
Exhibit 77: Data Table on Interferons - Year-over-year growth 2025-2030 (%)
Exhibit 78: Chart on Decarboxylase inhibitors - Market size and forecast 2025-2030 ($ million)
Exhibit 79: Data Table on Decarboxylase inhibitors - Market size and forecast 2025-2030 ($ million)
Exhibit 80: Chart on Decarboxylase inhibitors - Year-over-year growth 2025-2030 (%)
Exhibit 81: Data Table on Decarboxylase inhibitors - Year-over-year growth 2025-2030 (%)
Exhibit 82: Chart on Dopamine agonists - Market size and forecast 2025-2030 ($ million)
Exhibit 83: Data Table on Dopamine agonists - Market size and forecast 2025-2030 ($ million)
Exhibit 84: Chart on Dopamine agonists - Year-over-year growth 2025-2030 (%)
Exhibit 85: Data Table on Dopamine agonists - Year-over-year growth 2025-2030 (%)
Exhibit 86: Chart on Others - Market size and forecast 2025-2030 ($ million)
Exhibit 87: Data Table on Others - Market size and forecast 2025-2030 ($ million)
Exhibit 88: Chart on Others - Year-over-year growth 2025-2030 (%)
Exhibit 89: Data Table on Others - Year-over-year growth 2025-2030 (%)
Exhibit 90: Market opportunity by Drug Class ($ million)
Exhibit 91: Data Table on Market opportunity by Drug Class ($ million)
Exhibit 92: Chart on Route of Administration - Market share 2025-2030 (%)
Exhibit 93: Data Table on Route of Administration - Market share 2025-2030 (%)
Exhibit 94: Chart on Comparison by Route of Administration
Exhibit 95: Data Table on Comparison by Route of Administration
Exhibit 96: Chart on Oral - Market size and forecast 2025-2030 ($ million)
Exhibit 97: Data Table on Oral - Market size and forecast 2025-2030 ($ million)
Exhibit 98: Chart on Oral - Year-over-year growth 2025-2030 (%)
Exhibit 99: Data Table on Oral - Year-over-year growth 2025-2030 (%)
Exhibit 100: Chart on Injection - Market size and forecast 2025-2030 ($ million)
Exhibit 101: Data Table on Injection - Market size and forecast 2025-2030 ($ million)
Exhibit 102: Chart on Injection - Year-over-year growth 2025-2030 (%)
Exhibit 103: Data Table on Injection - Year-over-year growth 2025-2030 (%)
Exhibit 104: Chart on Transdermal - Market size and forecast 2025-2030 ($ million)
Exhibit 105: Data Table on Transdermal - Market size and forecast 2025-2030 ($ million)
Exhibit 106: Chart on Transdermal - Year-over-year growth 2025-2030 (%)
Exhibit 107: Data Table on Transdermal - Year-over-year growth 2025-2030 (%)
Exhibit 108: Market opportunity by Route of Administration ($ million)
Exhibit 109: Data Table on Market opportunity by Route of Administration ($ million)
Exhibit 110: Chart on End-user - Market share 2025-2030 (%)
Exhibit 111: Data Table on End-user - Market share 2025-2030 (%)
Exhibit 112: Chart on Comparison by End-user
Exhibit 113: Data Table on Comparison by End-user
Exhibit 114: Chart on Hospital pharmacy - Market size and forecast 2025-2030 ($ million)
Exhibit 115: Data Table on Hospital pharmacy - Market size and forecast 2025-2030 ($ million)
Exhibit 116: Chart on Hospital pharmacy - Year-over-year growth 2025-2030 (%)
Exhibit 117: Data Table on Hospital pharmacy - Year-over-year growth 2025-2030 (%)
Exhibit 118: Chart on Retail pharmacy - Market size and forecast 2025-2030 ($ million)
Exhibit 119: Data Table on Retail pharmacy - Market size and forecast 2025-2030 ($ million)
Exhibit 120: Chart on Retail pharmacy - Year-over-year growth 2025-2030 (%)
Exhibit 121: Data Table on Retail pharmacy - Year-over-year growth 2025-2030 (%)
Exhibit 122: Chart on Online pharmacy - Market size and forecast 2025-2030 ($ million)
Exhibit 123: Data Table on Online pharmacy - Market size and forecast 2025-2030 ($ million)
Exhibit 124: Chart on Online pharmacy - Year-over-year growth 2025-2030 (%)
Exhibit 125: Data Table on Online pharmacy - Year-over-year growth 2025-2030 (%)
Exhibit 126: Market opportunity by End-user ($ million)
Exhibit 127: Data Table on Market opportunity by End-user ($ million)
Exhibit 128: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibit 129: Chart on Market share by geography 2025-2030 (%)
Exhibit 130: Data Table on Market share by geography 2025-2030 (%)
Exhibit 131: Chart on Geographic comparison
Exhibit 132: Data Table on Geographic comparison
Exhibit 133: Chart on North America - Market size and forecast 2025-2030 ($ million)
Exhibit 134: Data Table on North America - Market size and forecast 2025-2030 ($ million)
Exhibit 135: Chart on North America - Year-over-year growth 2025-2030 (%)
Exhibit 136: Data Table on North America - Year-over-year growth 2025-2030 (%)
Exhibit 137: Chart on Regional Comparison - North America
Exhibit 138: Data Table on Regional Comparison - North America
Exhibit 139: Chart on US - Market size and forecast 2025-2030 ($ million)
Exhibit 140: Data Table on US - Market size and forecast 2025-2030 ($ million)
Exhibit 141: Chart on US - Year-over-year growth 2025-2030 (%)
Exhibit 142: Data Table on US - Year-over-year growth 2025-2030 (%)
Exhibit 143: Chart on Canada - Market size and forecast 2025-2030 ($ million)
Exhibit 144: Data Table on Canada - Market size and forecast 2025-2030 ($ million)
Exhibit 145: Chart on Canada - Year-over-year growth 2025-2030 (%)
Exhibit 146: Data Table on Canada - Year-over-year growth 2025-2030 (%)
Exhibit 147: Chart on Mexico - Market size and forecast 2025-2030 ($ million)
Exhibit 148: Data Table on Mexico - Market size and forecast 2025-2030 ($ million)
Exhibit 149: Chart on Mexico - Year-over-year growth 2025-2030 (%)
Exhibit 150: Data Table on Mexico - Year-over-year growth 2025-2030 (%)
Exhibit 151: Chart on Europe - Market size and forecast 2025-2030 ($ million)
Exhibit 152: Data Table on Europe - Market size and forecast 2025-2030 ($ million)
Exhibit 153: Chart on Europe - Year-over-year growth 2025-2030 (%)
Exhibit 154: Data Table on Europe - Year-over-year growth 2025-2030 (%)
Exhibit 155: Chart on Regional Comparison - Europe
Exhibit 156: Data Table on Regional Comparison - Europe
Exhibit 157: Chart on Germany - Market size and forecast 2025-2030 ($ million)
Exhibit 158: Data Table on Germany - Market size and forecast 2025-2030 ($ million)
Exhibit 159: Chart on Germany - Year-over-year growth 2025-2030 (%)
Exhibit 160: Data Table on Germany - Year-over-year growth 2025-2030 (%)
Exhibit 161: Chart on UK - Market size and forecast 2025-2030 ($ million)
Exhibit 162: Data Table on UK - Market size and forecast 2025-2030 ($ million)
Exhibit 163: Chart on UK - Year-over-year growth 2025-2030 (%)
Exhibit 164: Data Table on UK - Year-over-year growth 2025-2030 (%)
Exhibit 165: Chart on France - Market size and forecast 2025-2030 ($ million)
Exhibit 166: Data Table on France - Market size and forecast 2025-2030 ($ million)
Exhibit 167: Chart on France - Year-over-year growth 2025-2030 (%)
Exhibit 168: Data Table on France - Year-over-year growth 2025-2030 (%)
Exhibit 169: Chart on Italy - Market size and forecast 2025-2030 ($ million)
Exhibit 170: Data Table on Italy - Market size and forecast 2025-2030 ($ million)
Exhibit 171: Chart on Italy - Year-over-year growth 2025-2030 (%)
Exhibit 172: Data Table on Italy - Year-over-year growth 2025-2030 (%)
Exhibit 173: Chart on Spain - Market size and forecast 2025-2030 ($ million)
Exhibit 174: Data Table on Spain - Market size and forecast 2025-2030 ($ million)
Exhibit 175: Chart on Spain - Year-over-year growth 2025-2030 (%)
Exhibit 176: Data Table on Spain - Year-over-year growth 2025-2030 (%)
Exhibit 177: Chart on The Netherlands - Market size and forecast 2025-2030 ($ million)
Exhibit 178: Data Table on The Netherlands - Market size and forecast 2025-2030 ($ million)
Exhibit 179: Chart on The Netherlands - Year-over-year growth 2025-2030 (%)
Exhibit 180: Data Table on The Netherlands - Year-over-year growth 2025-2030 (%)
Exhibit 181: Chart on Asia - Market size and forecast 2025-2030 ($ million)
Exhibit 182: Data Table on Asia - Market size and forecast 2025-2030 ($ million)
Exhibit 183: Chart on Asia - Year-over-year growth 2025-2030 (%)
Exhibit 184: Data Table on Asia - Year-over-year growth 2025-2030 (%)
Exhibit 185: Chart on Regional Comparison - Asia
Exhibit 186: Data Table on Regional Comparison - Asia
Exhibit 187: Chart on China - Market size and forecast 2025-2030 ($ million)
Exhibit 188: Data Table on China - Market size and forecast 2025-2030 ($ million)
Exhibit 189: Chart on China - Year-over-year growth 2025-2030 (%)
Exhibit 190: Data Table on China - Year-over-year growth 2025-2030 (%)
Exhibit 191: Chart on Japan - Market size and forecast 2025-2030 ($ million)
Exhibit 192: Data Table on Japan - Market size and forecast 2025-2030 ($ million)
Exhibit 193: Chart on Japan - Year-over-year growth 2025-2030 (%)
Exhibit 194: Data Table on Japan - Year-over-year growth 2025-2030 (%)
Exhibit 195: Chart on India - Market size and forecast 2025-2030 ($ million)
Exhibit 196: Data Table on India - Market size and forecast 2025-2030 ($ million)
Exhibit 197: Chart on India - Year-over-year growth 2025-2030 (%)
Exhibit 198: Data Table on India - Year-over-year growth 2025-2030 (%)
Exhibit 199: Chart on South Korea - Market size and forecast 2025-2030 ($ million)
Exhibit 200: Data Table on South Korea - Market size and forecast 2025-2030 ($ million)
Exhibit 201: Chart on South Korea - Year-over-year growth 2025-2030 (%)
Exhibit 202: Data Table on South Korea - Year-over-year growth 2025-2030 (%)
Exhibit 203: Chart on Singapore - Market size and forecast 2025-2030 ($ million)
Exhibit 204: Data Table on Singapore - Market size and forecast 2025-2030 ($ million)
Exhibit 205: Chart on Singapore - Year-over-year growth 2025-2030 (%)
Exhibit 206: Data Table on Singapore - Year-over-year growth 2025-2030 (%)
Exhibit 207: Chart on Thailand - Market size and forecast 2025-2030 ($ million)
Exhibit 208: Data Table on Thailand - Market size and forecast 2025-2030 ($ million)
Exhibit 209: Chart on Thailand - Year-over-year growth 2025-2030 (%)
Exhibit 210: Data Table on Thailand - Year-over-year growth 2025-2030 (%)
Exhibit 211: Chart on Rest of World (ROW) - Market size and forecast 2025-2030 ($ million)
Exhibit 212: Data Table on Rest of World (ROW) - Market size and forecast 2025-2030 ($ million)
Exhibit 213: Chart on Rest of World (ROW) - Year-over-year growth 2025-2030 (%)
Exhibit 214: Data Table on Rest of World (ROW) - Year-over-year growth 2025-2030 (%)
Exhibit 215: Chart on Regional Comparison - Rest of World (ROW)
Exhibit 216: Data Table on Regional Comparison - Rest of World (ROW)
Exhibit 217: Chart on Brazil - Market size and forecast 2025-2030 ($ million)
Exhibit 218: Data Table on Brazil - Market size and forecast 2025-2030 ($ million)
Exhibit 219: Chart on Brazil - Year-over-year growth 2025-2030 (%)
Exhibit 220: Data Table on Brazil - Year-over-year growth 2025-2030 (%)
Exhibit 221: Chart on Saudi Arabia - Market size and forecast 2025-2030 ($ million)
Exhibit 222: Data Table on Saudi Arabia - Market size and forecast 2025-2030 ($ million)
Exhibit 223: Chart on Saudi Arabia - Year-over-year growth 2025-2030 (%)
Exhibit 224: Data Table on Saudi Arabia - Year-over-year growth 2025-2030 (%)
Exhibit 225: Chart on South Africa - Market size and forecast 2025-2030 ($ million)
Exhibit 226: Data Table on South Africa - Market size and forecast 2025-2030 ($ million)
Exhibit 227: Chart on South Africa - Year-over-year growth 2025-2030 (%)
Exhibit 228: Data Table on South Africa - Year-over-year growth 2025-2030 (%)
Exhibit 229: Chart on UAE - Market size and forecast 2025-2030 ($ million)
Exhibit 230: Data Table on UAE - Market size and forecast 2025-2030 ($ million)
Exhibit 231: Chart on UAE - Year-over-year growth 2025-2030 (%)
Exhibit 232: Data Table on UAE - Year-over-year growth 2025-2030 (%)
Exhibit 233: Chart on Argentina - Market size and forecast 2025-2030 ($ million)
Exhibit 234: Data Table on Argentina - Market size and forecast 2025-2030 ($ million)
Exhibit 235: Chart on Argentina - Year-over-year growth 2025-2030 (%)
Exhibit 236: Data Table on Argentina - Year-over-year growth 2025-2030 (%)
Exhibit 237: Chart on Turkey - Market size and forecast 2025-2030 ($ million)
Exhibit 238: Data Table on Turkey - Market size and forecast 2025-2030 ($ million)
Exhibit 239: Chart on Turkey - Year-over-year growth 2025-2030 (%)
Exhibit 240: Data Table on Turkey - Year-over-year growth 2025-2030 (%)
Exhibit 241: Chart on Egypt - Market size and forecast 2025-2030 ($ million)
Exhibit 242: Data Table on Egypt - Market size and forecast 2025-2030 ($ million)
Exhibit 243: Chart on Egypt - Year-over-year growth 2025-2030 (%)
Exhibit 244: Data Table on Egypt - Year-over-year growth 2025-2030 (%)
Exhibit 245: Chart on Chile - Market size and forecast 2025-2030 ($ million)
Exhibit 246: Data Table on Chile - Market size and forecast 2025-2030 ($ million)
Exhibit 247: Chart on Chile - Year-over-year growth 2025-2030 (%)
Exhibit 248: Data Table on Chile - Year-over-year growth 2025-2030 (%)
Exhibit 249: Market opportunity by geography ($ million)
Exhibit 250: Data Tables on Market opportunity by geography ($ million)
Exhibit 251: Impact of drivers and challenges in 2025 and 2030
Exhibit 252: Overview on criticality of inputs and factors of differentiation
Exhibit 253: Overview on factors of disruption
Exhibit 254: Impact of key risks on business
Exhibit 255: Companies covered
Exhibit 256: Company ranking index
Exhibit 257: Matrix on companies position and classification
Exhibit 258: AbbVie Inc. - Overview
Exhibit 259: AbbVie Inc. - Business segments
Exhibit 260: AbbVie Inc. - Key news
Exhibit 261: AbbVie Inc. - Key offerings
Exhibit 262: AbbVie Inc. - Segment focus
Exhibit 263: SWOT
Exhibit 264: Acadia Pharmaceuticals Inc. - Overview
Exhibit 265: Acadia Pharmaceuticals Inc. - Product / Service
Exhibit 266: Acadia Pharmaceuticals Inc. - Key offerings
Exhibit 267: SWOT
Exhibit 268: Amneal Pharmaceuticals Inc. - Overview
Exhibit 269: Amneal Pharmaceuticals Inc. - Business segments
Exhibit 270: Amneal Pharmaceuticals Inc. - Key offerings
Exhibit 271: Amneal Pharmaceuticals Inc. - Segment focus
Exhibit 272: SWOT
Exhibit 273: Bayer AG - Overview
Exhibit 274: Bayer AG - Business segments
Exhibit 275: Bayer AG - Key offerings
Exhibit 276: Bayer AG - Segment focus
Exhibit 277: SWOT
Exhibit 278: Biogen Inc. - Overview
Exhibit 279: Biogen Inc. - Product / Service
Exhibit 280: Biogen Inc. - Key offerings
Exhibit 281: SWOT
Exhibit 282: Bristol Myers Squibb Co. - Overview
Exhibit 283: Bristol Myers Squibb Co. - Product / Service
Exhibit 284: Bristol Myers Squibb Co. - Key news
Exhibit 285: Bristol Myers Squibb Co. - Key offerings
Exhibit 286: SWOT
Exhibit 287: Dr. Reddys Laboratories Ltd. - Overview
Exhibit 288: Dr. Reddys Laboratories Ltd. - Business segments
Exhibit 289: Dr. Reddys Laboratories Ltd. - Key news
Exhibit 290: Dr. Reddys Laboratories Ltd. - Key offerings
Exhibit 291: Dr. Reddys Laboratories Ltd. - Segment focus
Exhibit 292: SWOT
Exhibit 293: Eisai Co. Ltd. - Overview
Exhibit 294: Eisai Co. Ltd. - Business segments
Exhibit 295: Eisai Co. Ltd. - Key offerings
Exhibit 296: Eisai Co. Ltd. - Segment focus
Exhibit 297: SWOT
Exhibit 298: Eli Lilly and Co. - Overview
Exhibit 299: Eli Lilly and Co. - Product / Service
Exhibit 300: Eli Lilly and Co. - Key offerings
Exhibit 301: SWOT
Exhibit 302: F. Hoffmann La Roche Ltd. - Overview
Exhibit 303: F. Hoffmann La Roche Ltd. - Business segments
Exhibit 304: F. Hoffmann La Roche Ltd. - Key news
Exhibit 305: F. Hoffmann La Roche Ltd. - Key offerings
Exhibit 306: F. Hoffmann La Roche Ltd. - Segment focus
Exhibit 307: SWOT
Exhibit 308: GlaxoSmithKline Plc - Overview
Exhibit 309: GlaxoSmithKline Plc - Business segments
Exhibit 310: GlaxoSmithKline Plc - Key news
Exhibit 311: GlaxoSmithKline Plc - Key offerings
Exhibit 312: GlaxoSmithKline Plc - Segment focus
Exhibit 313: SWOT
Exhibit 314: Johnson and Johnson - Overview
Exhibit 315: Johnson and Johnson - Business segments
Exhibit 316: Johnson and Johnson - Key news
Exhibit 317: Johnson and Johnson - Key offerings
Exhibit 318: Johnson and Johnson - Segment focus
Exhibit 319: SWOT
Exhibit 320: Merck KGaA - Overview
Exhibit 321: Merck KGaA - Business segments
Exhibit 322: Merck KGaA - Key news
Exhibit 323: Merck KGaA - Key offerings
Exhibit 324: Merck KGaA - Segment focus
Exhibit 325: SWOT
Exhibit 326: Novartis AG - Overview
Exhibit 327: Novartis AG - Business segments
Exhibit 328: Novartis AG - Key news
Exhibit 329: Novartis AG - Key offerings
Exhibit 330: Novartis AG - Segment focus
Exhibit 331: SWOT
Exhibit 332: Pfizer Inc. - Overview
Exhibit 333: Pfizer Inc. - Business segments
Exhibit 334: Pfizer Inc. - Key news
Exhibit 335: Pfizer Inc. - Key offerings
Exhibit 336: Pfizer Inc. - Segment focus
Exhibit 337: SWOT
Exhibit 338: Inclusions checklist
Exhibit 339: Exclusions checklist
Exhibit 340: Currency conversion rates for US$
Exhibit 341: Research methodology
Exhibit 342: Information sources
Exhibit 343: Data validation
Exhibit 344: Validation techniques employed for market sizing
Exhibit 345: Data synthesis
Exhibit 346: 360 degree market analysis
Exhibit 347: List of abbreviations
Executive Summary
The following companies are recognized as the key players in the global global neurodegenerative diseases therapeutics market: AbbVie Inc., Acadia Pharmaceuticals Inc., Amneal Pharmaceuticals Inc., Bayer AG, Biogen Inc., Bristol Myers Squibb Co., Dr. Reddys Laboratories Ltd., Eisai Co. Ltd., Eli Lilly and Co., F. Hoffmann La Roche Ltd., GlaxoSmithKline Plc, H. Lundbeck AS, Johnson and Johnson, Merck KGaA, Mitsubishi Tanabe Pharma Corp., Novartis AG, Pfizer Inc., Sanofi SA, Sun Pharmaceutical Industries, Supernus Pharmaceuticals Inc..Commenting on the report, an analyst from the research team said: "The latest trend gaining momentum in the market is growing aging population and neurological disease burden."
According to the report, one of the major drivers for this market is the rapidly aging global demographic and rising disease prevalence.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- AbbVie Inc.
- Acadia Pharmaceuticals Inc.
- Amneal Pharmaceuticals Inc.
- Bayer AG
- Biogen Inc.
- Bristol Myers Squibb Co.
- Dr. Reddys Laboratories Ltd.
- Eisai Co. Ltd.
- Eli Lilly and Co.
- F. Hoffmann La Roche Ltd.
- GlaxoSmithKline Plc
- H. Lundbeck AS
- Johnson and Johnson
- Merck KGaA
- Mitsubishi Tanabe Pharma Corp.
- Novartis AG
- Pfizer Inc.
- Sanofi SA
- Sun Pharmaceutical Industries
- Supernus Pharmaceuticals Inc.
